An observational study in Metabolic Dysfunction Associated Steatotic Liver Disease, sponsored by Sohag University. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-14.
Sponsored by Sohag University · Observational
This study aims to evaluate circulating leptin levels in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Leptin is an adipokine involved in metabolism and inflammation. The study will assess the association between serum leptin levels and the presence or severity of MASLD compared to controls.
Sohag University is the lead sponsor of 1,218 studies on the registry; 627 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients attending the Gastroenterology and Hepatology outpatient clinics or inpatient departments at Sohag University Hospitals, along with healthy volunteers matched for age and sex.
Inclusion Criteria: Patient older than 18 years diagnosed with MASLD according to Delphi consensus criteria In addition to a control group of healthy individuals, matched to them in age, sex and number.
-
Exclusion Criteria: 1-Significant alcohol consumption (>20 g/day for females, >30 g/day for males).
2-Other causes of chronic liver disease:
Patients diagnosed with Metabolic Dysfunction-Associated Steatotic Liver Disease
Other: Serum Leptin Measurement
Other: Serum Leptin Measurement
evaluate circulating leptin levels in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Serum Leptin Levels
Serum concentration of leptin measured in ng/mL using enzyme-linked immunosorbent assay (ELISA) in patients with MASLD compared to controls.
Time frame: At baseline (upon study enrollment for each participant)
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.